A comprehensive and accessible guide to prescription, over-the-counter (OTC), and complementary and alternative medications that could exacerbate heart failure was recently released by the American Heart Association (AHA).
Metformin appears to be a safe option for glycemic control in heart failure patients, according to a recent meta-analysis. ... However, a number of studies in animal models of heart failure have suggested potential benefits of metformin, the authors noted
A possible increase in heart failure associated with saxagliptin (Onglyza and Kombiglyze XR) is also being investigated by the FDA. ... The agency recently requested data from a manufacturer-sponsored trial which found an increased rate of
patients with heart failure, and its measurement has been proposed as a possible tool for helping manage this condition. ... Patients were followed in outpatient heart failure clinics and had prespecified visits 1, 6, and 12 months after randomization.
Readmissions for heart failure, bleeding, ischemic stroke, stroke, and other cardiovascular causes were not significantly different between the groups. ... We observed a mortality rate >40% at 1 year and 70% by 3 years among untreated patients with heart
When his heart failure patient kept getting hospitalized with related complications, Ben Powers, MD, worried that something wasn't quite connecting. ... Peterson found that heart failure patients with low health literacy faced a higher risk of overall
Cost-effectiveness was analyzed in subgroups of patients with class II or class III/IV heart failure. ... The study's outcome measures were life-years, quality-adjusted life-years (QALYs), hospitalizations for heart failure, and incremental
Ischemic heart disease is associated with poor prognosis in heart failure patients with type 2 diabetes, according to a recent study. ... A total of 35,163 patients with heart failure were included in the study.
https://acpinternist.org/weekly/archives/2015/01/27/5.htm. Nine interventions for transitions of care in heart failure may assist in achieving optimal clinical and patient-centered outcomes, according to ... Ensure that qualified and trained heart
Sacubitril/valsartan (Entresto) tablets for the treatment of heart failure. In a clinical trial of more than 8,000 patients, the drug was shown to reduce the rate of cardiovascular death ... Most patients were also receiving approved heart failure